sunesis pharmaceuticals inc
(SNSS:Consolidated Issue listed on NASDAQ Capital Market)
SNSS
Industry Average
Profitability - sunesis pharmaceuticals inc (SNSS)
|
Return on Assets Industry Comparison
-42.34%
|
Return on Equity Industry Comparison
-527.60%
|
|
|
Return on Capital Industry Comparison
-85.42%
|
Margin Analysis - sunesis pharmaceuticals inc (SNSS)
|
Gross Margin Industry Comparison
100.00%
|
Levered Free Cash Flow Margin Industry Comparison
-58.88%
|
|
|
EBITDA Margin Industry Comparison
-584.59%
|
SG&A Margin Industry Comparison
164.20%
|
Asset Turnover - sunesis pharmaceuticals inc (SNSS)
|
Total Assets Turnover Industry Comparison
0.1x
|
Accounts Receivables Turnover Industry Comparison
--
No data available
|
|
|
Fixed Assets Turnover Industry Comparison
112.6x
|
Inventory Turnover Industry Comparison
--
No data available
|
Credit Ratios - sunesis pharmaceuticals inc (SNSS)
|
Current Ratio Industry Comparison
1.7x
|
Quick Ratio Industry Comparison
1.7x
|
Long-Term Solvency - sunesis pharmaceuticals inc (SNSS)
|
Total Debt/Equity Industry Comparison
2,159.5x
|
Total Liabilities/Total Assets Industry Comparison
98.2x
|
Growth Over Prior Year - sunesis pharmaceuticals inc (SNSS)
|
Total Revenue Industry Comparison
474.30%
|
Tangible Book Value Industry Comparison
-92.48%
|
|
|
EBITDA Industry Comparison
3.06%
|
Gross Profit Industry Comparison
474.30%
|
|
|
Receivables Industry Comparison
--
No data available
|
Inventory Industry Comparison
--
No data available
|
|
|
Diluted EPS Before Extra Industry Comparison
9.41%
|
Capital Expenditures Industry Comparison
--
No data available
|
|
|
Cash From Ops. Industry Comparison
-57.40%
|
Levered Free Cash Flow Industry Comparison
-68.39%
|
| Recently Viewed | |||
| SNSS:US | $5.11 USD | +0.09 |  |
| Company | Last | Change |
| BioDelivery Sciences International Inc | $4.66 USD | +0.22 |
| EpiCept Corp | $0.06 USD | 0.00 |
| NeurogesX Inc | $0.01 USD | 0.00 |
| Pozen Inc | $5.12 USD | +0.09 |
| View Industry Companies | ||
Industry Analysis
SNSS
Industry Average
| Valuation | SNSS | Industry Range |
| Price/Earnings | NM | Not Meaningful |
| Price/Sales | 45.1x |
|
| Price/Book | 234.7x |
|
| Price/Cash Flow | NM | Not Meaningful |
| TEV/Sales | 30.3x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact SUNESIS PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
